SAN FRANCISCO, CA—A new paper out of the iPrEx study—a randomized, placebo-controlled trial of daily oral HIV pre-exposure prophylaxis (PrEP) in men and transgender women who have sex with men—reported no link between taking Truvada for oral PrEP and experiencing depression.
SAN FRANCISCO, CA—Scientists from the Gladstone Institutes have discovered a way to prevent the development of multiple sclerosis (MS) in mice.
SAN FRANCISCO, CA—New research from the Gladstone Institutes for the first time provides strong evidence that HIV latency is controlled not by infected host cells, but by the virus itself.
SAN FRANCISCO, CA—Back-to-back studies from researchers at the Gladstone Institutes have exposed new battle tactics employed by two deadly viruses: hepatitis C (HCV) and the Kaposi’s sarcoma-associated herpesvirus (KSHV).
SAN FRANCISCO, CA—Leor Weinberger, PhD, an associate investigator at the Gladstone Institutes, has been elected to the 2015 class of the College of Fellows for the American Institute for Medical and Biological Engineering (AIMBE).
SAN FRANCISCO and NEW YORK—Researchers from Weill Cornell Medical College and the Gladstone Institutes have found a way to prevent noise-induced hearing loss in a mouse using a simple chemical compound that is a precursor to vitamin B3.
SAN FRANCISCO—In the fight against HIV, microbicides—chemical compounds that can be applied topically to the female genital tract to protect against sexually transmitted infections—have been touted as an effective alternative to condoms.
SAN FRANCISCO, CA—A team of scientists at the Gladstone Institutes has identified a new way to make latent HIV reveal itself, which could help overcome one of the biggest obstacles to finding a cure for HIV infection.
SAN FRANCISCO, CA—Research led by scientists at the Gladstone Institutes has identified the precise chain of molecular events in the human body that drives the death of most of the immune system’s CD4 T cells as an HIV infection leads to AIDS.
SAN FRANCISCO, CA—In 2012 the HIV antiretroviral drug Truvada became the first and only medication approved by the FDA for HIV prevention.